the Abx (−) group showed a trend towards to a shorter OS [9.2 months (95% CI 6.2–13.7) vs.12.5 months (95% CI 9.3–21.2)], but it was not statistically significant [log-rank p = 0. 085; HR 1.50 (95% CI 0.95–2.38); p = 0.085; Fig. 1 b].
← all excerpts
Association between antibiotic use, immune-related adverse events, and efficacy of immunotherapy in esophageal squamous cell carcinoma.
1
—
—